Elanco Animal Health Q2 Adjusted EPS $0.18 Beats $0.05 Estimate, Sales $1.06B Beat $1.04B Estimate
Portfolio Pulse from Benzinga Newsdesk
Elanco Animal Health (NYSE:ELAN) reported Q2 earnings of $0.18 per share, beating the analyst consensus estimate of $0.05 by 260 percent. However, this is a 53.85 percent decrease from the same period last year. The company also reported quarterly sales of $1.06 billion, beating the analyst consensus estimate of $1.04 billion by 2.03 percent, but this is a 10.04 percent decrease from the same period last year.
August 07, 2023 | 10:34 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Elanco's Q2 earnings and sales beat estimates but are down from last year. This mixed result could lead to uncertain market reactions.
Elanco's earnings and sales beat analyst estimates, which is typically positive for the stock. However, the significant decreases from the same period last year could offset this positive impact, leading to a neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100